TableĀ 3

Receiver operating characteristic (ROC) curve analysis of pancreatic juice mutation concentrations (overall 115#)

KRAS onlyGNAS onlyTP53 onlyTP53+SMAD4All 9 genes
PDAC vs controlsAUC0.740.610.790.820.89
95% CI of AUC0.62 to 0.870.46 to 0.760.68 to 0.910.72 to 0.930.80 to 0.97
Specificity91.7%83.4%100.0%100.0%83.4%
Sensitivity50.0%38.2%58.8%64.7%85.3%
p Value0.0020.1740.0002<0.0001<0.0001
IPMN vs controlsAUC0.740.670.630.630.85
95% CI of AUC0.62 to 0.850.55 to 0.800.51 to 0.760.51 to 0.760.76 to 0.93
Specificity83.4%83.4%100.0%100.0%83.4%
Sensitivity57.1%51.8%26.8%26.8%73.2%
p Value0.0010.0150.0580.058<0.0001
PDAC vs IPMNAUC0.560.560.690.730.69
95% CI of AUC0.43 to 0.700.43 to 0.680.58 to 0.810.62 to 0.850.56 to 0.81
Specificity42.9%51.8%73.2%73.2%85.7%
Sensitivity52.9%61.8%58.8%64.7%52.9%
p Value0.2900.3240.0020.00020.003
  • AUC, area under the curve; IPMN, intraductal papillary mucinous neoplasm; PDAC, pancreatic ductal adenocarcinoma.